Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ: TMCI )

8.710 +0.460 (+5.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 Next >
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Appoints Guy Guglielmino as Chief Commercial Officer
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation at Stifel 2024 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the UBS Global Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
Positions Treace to Significantly Increase Penetration into Overall Bunion Market and Expand Surgeon Customer Base 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
Insiders are buying the dips in these three stocks, which suggests a rebound is coming. There are reasons the market dipped, but the sell-offs are overdone. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.